A carregar...
Suppression of immune regulatory cells with combined therapy of celecoxib and sunitinib in renal cell carcinoma
OBJECTIVE: To observe the the potential benefit of sunitinib in combination with cyclooxygenase-2(COX-2) inhibitor in renal cell carcinoma therapy. METHODS: 769-p cell lines were treated with sunitinib, celecoxib, or in combination at different concentrations respectively. We investigated the expres...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5352087/ https://ncbi.nlm.nih.gov/pubmed/27926489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13774 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|